Immediate Impact

2 by Nobel laureates 7 from Science/Nature 53 standout
Sub-graph 1 of 23

Citing Papers

Pancreatic cancer
2025 Standout
Artificial intelligence in drug development
2025 Standout
2 intermediate papers

Works of Shu Shimada being referenced

Loss of KDM6A characterizes a poor prognostic subtype of human pancreatic cancer and potentiates HDAC inhibitor lethality
2018
Acquired Resistance with Epigenetic Alterations Under Long-Term Antiangiogenic Therapy for Hepatocellular Carcinoma
2017

Author Peers

Author Last Decade Papers Cites
Shu Shimada 989 347 589 42 1.4k
Kejun Nan 1055 425 822 59 1.6k
Hengjun Gao 1120 301 661 72 1.6k
Ming-hua Zhu 822 286 458 49 1.2k
Yulong Shang 1180 301 743 52 1.7k
Tae Matsumura 1076 284 893 66 1.6k
Shanzhou� Huang 881 356 577 67 1.3k
Hung‐Wei Pan 861 267 512 27 1.3k
Renan Jin 674 264 454 33 1.2k
Guoqiang Qiu 771 195 512 54 1.1k
Huahong Xie 804 247 438 42 1.1k

All Works

Loading papers...

Rankless by CCL
2026